Looking forward to my Fresno talk
Wed 23 September at 08:48 PM

Papers

I've Read This
I've Read This
I've Read This

Die Konvergenz der Governance von Wissenschaft und Technik mit der Governance des "Ableism" The convergence of science and technology governance with the governance of Ableism

TECHNIKFOLGENABSCHÄTZUNG – Theorie und Praxis Herausgeber: Institut für Technikfolgenabschätzung und Systemanalyse (ITAS) Technology assessment Theorie and Praxis. Publisher Institute for Technology assessment and system analysis ITAS

I've Read This
  • 14 Views
I've Read This

Human Enhancement Study

co-authored with Coenen Schuijff, Smits, Klaassen, Hennen, Rader  and published by Directorate General for internal policies, Policy Dept. A: Economic and Scientific Policy Science and Technology Options Assessments European Parliament

Abstract
The study attempts to bridge the gap between visions on human
enhancement (HE) and the relevant technoscientific developments. It
outlines possible strategies of how to deal with HE in a European
context, identifying a reasoned pro-enhancement approach, a
reasoned restrictive approach and a case-by-case approach as viable
options for the EU. The authors propose setting up a European body
(temporary committee or working group) for the development of a
normative framework that guides the formulation of EU policies on HE.

I've Read This
  • 8 Views

Oscar Pistorius and the Future Nature of Olympic, Paralympic and Other Sports

SCRIPT-ed 2008 A Journal of Law, Technology & Society

I've Read This
  • 135 Views

Why NBIC? Why human performance enhancement?

European Journal of Social Science Research, Vol 21,No.1,pp.25-40, 2008

A 2001 U.S. workshop with the title "Nanotechnology, Biotechnology, Information Technology and Cognitive Science (NBIC): Converging Technologies for Improving Human Performance" introduced the convergence of various sciences and technologies based on their nanoscale properties. It highlighted BIC as the science and technologies converging on the nanoscale. However many other sciences and technologies with nanoscale components exist, such as chemistry and material sciences. Furthermore the workshop chose human performance enhancement as its case study of application despite various other possible applications that could have been chosen. This paper addresses the questions why the workshop organizers (a) introduced nanoscale as a convergence concept, (b) chose BIC as the convergence examples and (c) chose human performance enhancement as their application. The paper provides some thoughts as to the success and consequences of that strategy.

I've Read This

Should we 'cure' aging?

Studies in Ethics, Law, and Technology Vol 1 Issue 1, 2007

This is a reply to the discussion piece Life Span Extension Research and Public Debate: Societal Considerations, Studies in Ethics, Law, and Technology by Audrey de Grey.

Having read the article there seem to be four messages. The first being, that longevity/immortality research faces rejection, resistance and neglect from `classic anti-aging' researchers, policy makers, the funding system and the public. The second being that the `pro-aging' trance is illogical; the third being that not pushing for longevity and immortality research is immoral; and the fourth being that so far no valid reason for opposing longevity and immortality has been generated and that we will deal with potential problems if and when they appear. My message in this invited comment is 1) that de Grey is right with his first point; 2) that his second point is debatable and depends on certain assumptions; 3) that his third point is even on weaker feet and debatable (Morals and ethics are social and cultural constructions and depending on ones frame of reference something can be seen as moral and ethical or not. This is a whole different paper as to who decides which morals and ethics are right and wrong and can't be covered here.) and 4) that the longevity and immortality research exhibits the same discourse problems as the other new and emerging technology discourses, namely that its makes light of potential and real social risks that it tailors to a minority of the world and ignores the marginalized majority of the world.

I've Read This

Bio-tech, NanoBio-Tech, SynBio-tech, NanoSynBio-tech? The changing face of biotech law? (Part I)

Journal of International Biotechnology Law JIBL Vol. 4 Issue 5 September 177-186, 2007

I've Read This

Bio-tech, NanoBio-Tech, SynBio-tech, NanoSynBio-tech? The changing face of biotech law? (Part II)

Journal of International Biotechnology Law JIBL Vol. 4 Issue 6 November 221-227

I've Read This

"New and Emerging Sciences and Technologies, Ableism, Transhumanism and Religion, Faith, Theology and Churches"

Madang; International Journal of Contextual Theology in East Asia, Vol. 7 (June 2007) 79-112

I've Read This

"Nano-Engagement: Some critical issues

Journal of Health and Development (India)Vol. 3 No 1-2, pp. 9-29, 2007

I've Read This

"The triangle of Enhancement Medicine, Disabled people and the concept of Health: A new challenge for HTA, health research and health policy"a 220 page report

Published by the Health Technology Assessment Unit of the Alberta Heritage Foundation for medical research, 2005/2006

I've Read This
  • 22 Views
 

Academia © 2009